Online citations, reference lists, and bibliographies.
← Back to Search

Functional Polymeric Nanoparticles: An Efficient And Promising Tool For Active Delivery Of Bioactives.

M. Nahar, T. Dutta, Senthilkumar Murugesan, Abhay Asthana, D. Mishra, V. Rajkumar, M. Tare, Surbhi Saraf, N. Jain
Published 2006 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Nanotechnology is a multidisciplinary field and has achieved breakthroughs in bioengineering, molecular biology, diagnostics, and therapeutics. A recent advance in nanotechnology is the development of a functional nanosystem by incorporation, adsorption, or covalent coupling of polymers, carbohydrates, endogenous substances/ligands, peptides, proteins, nucleic acids, and polysaccharides to the surface of nanoparticles. Functionalization confers a wide array of interesting properties such as stealth characteristics, a bioadhesive property, and that it prevents aggregation of nanoparticles, imparts biostability and solubility, reduces toxicity, and provides site-specific delivery. This makes the nanosystem an intelligent tool for diagnostics, prognostics, and controlled and sustained delivery of protein, peptide, pDNA, and other therapeutic agents to specific targets (tissue, cell, and intracellular). Various types of functional nanosystems, such as carbon nanotubes, quantum dots, polymeric micelles, dendrimers, metallic nanoparticles, and liposomes, are being extensively explored. However, high tissue accumulation of nonbiodegradable nanoparticles has caused toxicity problems and rendered them as not-so-popular therapeutic and diagnostic systems. The toxicity and safety of nonbiodegradable nanoparticles are subject to future research. Polymeric nanoparticles have offered attractive alternative modules due to biocompatibility, nonimmunogenicity, nontoxicity, biodegradability, simple preparation methods, high physical stability, possibility of sustained drug release, and higher probability for surface functionalization. Depending on properties that have been modified, polymeric nanoparticles can be grouped in to four classes, namely, stealth, polysaccharide decorated biomimetic, bioadhesive, and ligand-anchored functional polymeric nanoparticles (f-PNPs). This review explores the ligand-anchored f-PNP as a carrier for active delivery of bioactives, envisaged to date. This review also details the ligands available for conjugation, their method of coupling to nanoparticles, and applications of f-PNPs in anticancer drug delivery, oral delivery, gene delivery, vaccine delivery, and intracellular delivery; site-specific delivery to liver, macrophages, lymphatics, and brain; and miscellaneous applications. This review also addresses formidable challenges encountered, and proposes some future strategies for development of a promising site-specific active delivery system.



This paper is referenced by
HER-2 targeted immunonanoparticles for breast cancer chemotherapy
R. Dhankar (2011)
10.2217/fmb.13.68
Paracoccidioidomycosis: eco-epidemiology, taxonomy and clinical and therapeutic issues.
A. Bocca (2013)
10.1039/b806854m
Activatable imaging probes with amplified fluorescent signals.
S. Lee (2008)
10.1088/2053-1591/ab50a6
Amphiphilic polypeptide P23: design, synthesis, self-assembly and its encapsulation effect on doxorubicin
F. Ge (2019)
10.1016/j.phrs.2009.12.011
Enabling individualized therapy through nanotechnology.
J. Sakamoto (2010)
10.1016/j.tiv.2013.01.016
Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: a quantitative method for oxidative stress assessment of nanoparticle-treated cells.
A. Aranda (2013)
10.1007/978-3-030-21621-4_17
Interfacing Biology Systems with Nanoelectronics for Nanodevices
Loutfy H. Madkour (2019)
Ultrasonic Treatment of Nanoparticles for Pharmaceuticals
(2011)
10.2174/138161281941131219123329
Current progresses on nanodelivery systems for the treatment of neuropsychiatric diseases: Alzheimer's and schizophrenia.
A. Silva (2013)
10.1016/j.nano.2008.04.003
Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues.
M. Foldvari (2008)
10.18297/ETD/2800
Advances in tumor-targeted therapy using nanomedicine.
Divya Karukonda (2017)
10.1155/2007/69036
Significance of Nano- and Microtopography for Cell-Surface Interactions in Orthopaedic Implants
M. Jäger (2007)
10.1201/B10846-10
Transmucosal and Ocular Drug Delivery
Vasant V. Ranade (2011)
Synthesis and characterization of polyacrylamide based hydrogel containing magnesium oxide nanoparticles for antibacterial applications
Seyed Ali Asgharzadehahmadi (2012)
10.1007/978-1-60761-579-8_9
Reducing nanotube cytotoxicity using a nano-combinatorial library approach.
Qiu Zhang (2010)
10.1517/17425240903167934
Quantum dots: a powerful tool for understanding the intricacies of nanoparticle-mediated drug delivery
J. Delehanty (2009)
10.1080/21691401.2019.1616553
Oral delivery of indinavir using mPEG-PCL nanoparticles: preparation, optimization, cellular uptake, transport and pharmacokinetic evaluation
Masoumeh Kurd (2019)
10.1201/B13757-20
Polymer-Based Colloidal Aggregates as a New Class of Drug Delivery Systems
C. Cametti (2013)
10.4018/978-1-4666-5824-0.CH018
Implementation of Nanoparticles in Cancer Therapy
Ece Bayir (2014)
10.1039/c4cs00339j
Dendritic glycopolymers based on dendritic polyamine scaffolds: view on their synthetic approaches, characteristics and potential for biomedical applications.
D. Appelhans (2015)
10.3390/cancers2021251
Exogenous Molecular Probes for Targeted Imaging in Cancer: Focus on Multi-modal Imaging
B. Joshi (2010)
Brain gene therapy: triumph and future of nanotechnology
R. I. Castro (2012)
10.1016/j.bmc.2019.04.011
Is it possible to track intracellular chitosan nanoparticles using magnetic nanoparticles as contrast agent?
Anielle Carvalho Bandeira (2019)
10.1016/j.addr.2008.08.002
Hydrogel nanoparticles in drug delivery.
M. Hamidi (2008)
10.1016/J.FOODHYD.2019.04.042
Development of hollow kafirin-based nanoparticles fabricated through layer-by-layer assembly as delivery vehicles for curcumin
X. Li (2019)
10.1002/9781119962977.CH16
Target-Specific Chitosan-Based Nanoparticle Systems for Nucleic Acid Delivery
Shardool Jain (2012)
Advancement of Nanopharmaceutics in Drug Delivery
Dinesh (2016)
10.3109/10731199.2010.494578
Advances in Novel Drug Delivery Strategies for Breast Cancer Therapy
Ritu Dhankhar (2010)
10.1016/j.colsurfb.2017.06.024
Magnetic particles for in vitro molecular diagnosis: From sample preparation to integration into microsystems.
Tienrat Tangchaikeeree (2017)
10.1021/la401891f
PEG-stabilized core-shell surface-imprinted nanoparticles.
E. Moczko (2013)
10.1021/JP9060329
Resonance Energy Transfer Between Luminescent Quantum Dots and Diverse Fluorescent Protein Acceptors.
Igor L. Medintz (2009)
10.3109/02652040903518460
Preparation and evaluation of thiomer nanoparticles via high pressure homogenization
H. Hoyer (2010)
See more
Semantic Scholar Logo Some data provided by SemanticScholar